1 The presence and characteristics of P2X receptors on neurons of the rat major pelvic ganglia (MPG) have been studied using whole cell voltage-clamp, in situ hybridization and immunohistochemistry. 2 Rapid application of ATP (100 mM) to isolated rat MPG neurons induced moderately large inward currents (0.33 ± 5.3 nA) in 39% of cells (108/277). The response to ATP occurred very rapidly, with an increase in membrane conductance, and desensitized slowly. 3 The concentration-response curve for ATP yielded an EC 50 of 58.9 mM. The agonist pro®le was ATP52MeSATP=ATPgS4BzATP, while a,b-MeATP, b,g-MeATP, UTP and ADP were all inactive at concentrations up to 100 mM. 4 The response to ATP was antagonized by suramin (pA 2 =5.6), reactive blue-2 (IC 50 =0.7 mM) and pyridoxalphosphate-6-azophenyl-2',4'-disulphonic acid (PPADS). 5 Lowering the pH from 7.4 to 6.8 produced a marked potentiation (to 339% of control) of the responses to ATP (30 mM), while raising the pH to 8.0 attenuated the responses (to 20% of control). The EC 50 s for ATP were 28.8, 58.9 and 264 mM at pH 6.8, 7.4 and 8.0, respectively. 6 Co-application of ATP with Zn 2+ produced a marked enhancement of the responses to ATP, with an EC 50 of 9.55 mM. In the presence of Zn 2+ (30 mM), the EC 50 for ATP was decreased to 4.57 mM. 7 In situ hybridization revealed that the P2X receptor transcripts levels in rat MPG neurons are P2X 2 4P2X 4 4P2X 1 , P2X 3 , P2X 5 and P2X 6 . The immunohistochemical staining revealed a small number of neurons with strong P2X 2 immunoreactivity. 8 In conclusion, our results indicate that there are P2X receptors present on MPG neurons. The pharmacological characteristics of these receptors, the in situ hybridization and immunohistochemical evidence are consistent with them being of the P2X 2 subtype, or heteromultimers, with P2X 2 being the dominant component.
Introduction
Adenosine 5'-triphosphate (ATP) acts at cell-surface purinoceptors of two distinct types: P2X receptors which are the ligand-gated cation channels (ionotropic), and the G-protein coupled (metabotropic) P2Y receptors (Abbracchio & Burnstock, 1994) . So far, seven P2X receptor subtypes have been cloned, with dierent amino acid sequences and characteristics, including the agonist pro®les, desensitization and sensitivities to antagonists. (Valera et al., 1994; Brake et al., 1994; Chen et al., 1995; Bo et al., 1995; Collo et al., 1996; Surprenant et al., 1996) . These P2X receptor subtypes also demonstrate dierent pH sensitivity (King et al., 1996; Stoop et al., 1997) , and modulation by Zn 2+ (Wildman et al., 1998) . The pharmacological pro®les of the recombinant P2X receptors do not always match those of the endogenous P2X receptors; thus, it has been suggested that some native P2X receptors are heteromultimeric combinations of P2X subunits .
The P2X receptors have been studied in a number of neurons, including sensory (Krishtal et al., 1983; Bean, 1990; Robertson et al., 1996) , sympathetic (Cloues et al., 1993) , parasympathetic (Fieber & Adams, 1991; Nishimura & Tokimasa, 1996) , myenteric (Zhou & Galligan, 1996; Barajas-LoÂ pez et al., 1996) and central (Edwards et al., 1992) neurons. While the extent of the receptor characterization varies amongst these studies, the P2X receptors demonstrate dierent properties, indicating the presence of dierent subtypes on these neurons (Khakh et al., 1995) .
The neurons providing motor innervation to the bladder and pelvic viscera originate in the pelvic plexus. In most mammals, this is a diuse and extensive plexus comprised of many widely dispersed ganglia with multiple interconnections. In the rat however, this plexus is much simpler and consists of a pair of major pelvic ganglia (MPG) and four to six small accessory ganglia (Purinton et al., 1973) . Thus, while atypical, this makes the rat a convenient experimental animal. Anatomically, the MPG are unique amongst autonomic ganglia in that neurons of the MPG are a mixture, receiving both sympathetic and parasympathetic inputs from preganglionic ®bres travelling within the hypogastric and the pelvic nerves, respectively (Keast, 1995) .
In this study, we sought to determine the presence of P2X receptors on neurons of the rat MPG, to pharmacologically characterize them, and to correlate this with the in situ hybridization and immunohistochemical evidence. Furthermore, it enables us to make comparisons with purinoceptors present on other neurons, and with heterologously expressed receptors.
Methods

Electrophysiology
Isolation of neurons Single neurons of the MPG from 17-day old male Sprague-Dawley rats were enzymatically isolated. The rats were killed by stunning and cervical dislocation, and the MPG, located on the lateral surfaces of the prostate gland (Langworthy, 1965) , were rapidly dissected out, and placed in Leibovitz's L-15 medium (Life Technologies, Paisley, U.K.). The ganglia were desheathed and 3 ± 4 deep cuts were made in each before incubation in 4 ml Ca 2+ / Mg 2+ -free Hank's Balanced Salt Solution with 10 mM HEPES pH 7 buer (HBSS) (Life Technologies) containing 1.5 mg ml 71 collagenase (Class-II, Worthington Biochemical Corporation, Reading, U.K.) and 6 mg ml 71 BSA (Sigma, Poole, U.K.) at 378C for 40 min. The ganglia were then incubated with 4 ml HBSS containing 1 mg ml 71 trypsin (Sigma) at 378C for 15 min. The solution was replaced with 3 ml growth medium comprising L-15 medium supplemented with 50 ng ml 71 nerve growth factor, 10% bovine serum, 2 mg ml 71 NaHCO 3 , 5.5 mg ml 71 glucose, 200 IU ml 71 penicillin and 200 mg ml 71 streptomycin. The ganglia were dissociated into single neurons by gentle trituration with two ®re polished glass pipettes of decreasing diameter. The cells were then centrifuged at 900 r.p.m. for 5 min, resuspended in 1 ml growth medium and plated onto 35 mm Petri dishes coated with 10 mg ml 71 laminin (Sigma). Cells were maintained at 378C in a humidi®ed atmosphere containing 5% CO 2 and used between 3 and 48 h after plating.
Whole cell voltage-clamp recording Whole cell voltage-clamp recording was carried out at room temperature using an Axopatch 200B ampli®er (Axon Instruments, Foster City, CA, U.S.A.). Membrane potential was held at 770 mV. External solution contained (mM): NaCl 154, KCl 4.7, MgCl 2 1.2, CaCl 2 2.5, HEPES 10, Glucose 5.6, the pH was adjusted to 7.4 using NaOH. Recording electrodes were made from thin-walled glass capillary tubes with ®ne ®lament (GC 150TF; Clark Electromedical Instruments, Reading, U.K.) using a two stage puller (PP-830, Narishige, Tokyo, Japan), ®re polished, and had resistances of 2 ± 4 MO when ®lled with an internal solution containing (mM): citric acid 56, MgCl 2 3, CsCl 10, NaCl 10, HEPES 40, EGTA 0.1, TEACl 10, and the pH adjusted to 7.2 using CsOH. Data were acquired using pCLAMP software (Axon Instruments). Signals were ®ltered at 2 kHz.
Drugs were applied in two ways. In some experiments, agonists were applied rapidly by use of a solenoid valvecontrolled U-tube system placed very near the cell (Krishtal & Pidoplichko, 1980) . In other experiments where antagonists were used, drugs were applied rapidly through a seven-barrel manifold composed of fused glass capillaries inserted into a common outlet tube with a tip diameter of *200 mm (Dunn et al., 1996) . Solutions were delivered by gravity¯ow from independent reservoirs placed above the preparation. Applications of agonists (over 3 ± 5 s) were separated by intervals of 2 ± 3 min, which were sucient for responses to be reproducible. Antagonists were present for 2 ± 3 min before and during the reapplication of agonists. Schild analysis was performed by conducting a 2+2 assay (Arunlakshana & Schild, 1959) . Brie¯y, two-point ATP log concentration-response lines were obtained under control conditions, then in the presence of various concentrations of the antagonist. The eect of the antagonist was expressed as the dose-ratio, and the pA 2 value determined from the Schild Plot. Each concentration of the antagonist was tested on a dierent sample of cells.
All responses were normalized to that evoked by ATP (100 mM) in the same cell, unless otherwise stated. All data were expressed as the means+s.e.mean. The concentrationresponse data were ®tted with the Hill equation: Y=A/[1+(K/ X) n ], where: A is the maximum eect, K is the EC 50 , and n is the Hill coecient, using Prism v1.03, GraphPad. In this study, because agonist concentrations exceeding 300 mM were not used, the concentration-response curves did not always reach a maximum. However, the ATP concentration-response curve in the presence of 30 mM Zn 2+ reached a clear maximum (see Figure 7b ). Therefore, unless otherwise stated, agonist concentration-response curves were constrained to this maximum (1.55). Traces were acquired using pCLAMP (Axon Instruments) and plotted using Origin (Microcal, Northampton, MA, U.S.A). Statistical analysis (Student's t-test) was performed using Instat.
In situ hybridization and immunohistochemistry
Tissue preparation The MPG from 17-day old male SpragueDawley rats were dissected as described above. They were rapidly frozen by immersion in 7708C isopentane for 2 min, cut into 10 mm sections in a cryostat, thaw-mounted on poly-Llycine-coated slides and air-dried. The sections were then ®xed in 4% formaldehyde and 0.03% picric acid in 0.1 M phosphate buer, pH 7.4 for 10 min. After being washed 365 min in phosphate buered saline (PBS), they were processed for in situ hybridization and immunohistochemistry.
In situ hybridization Sense and anti-sense digoxigeninlabelled cRNA probes were synthesised with a DIG-RNA Labelling Kit (Boehringer Mannheim, Lewes, U.K.) using truncated rP2X 1 ± 6 cDNAs as the templates. The cRNA sequences were corresponding to the nucleotide sequence 1 ± 713 in rP2X 1 cDNA (Genbank X80477), 1 ± 994 in rP2X 2 cDNA (Genbank U14414), 1 ± 673 in rP2X 3 cDNA (Genbank X90651), 1 ± 670 in rP2X 4 cDNA (Genbank X91200), 1 ± 1257 in rP2X 5 cDNA (Genbank X92069) and 1 ± 581 in rP2X 6 cDNA (Genbank X92070).
In situ hybridization was carried out using a method modi®ed from HoÈ e¯er et al. (1986) . Brie¯y, ganglia sections which had been treated as described above were washed in 0.1 M glycine/PBS and in 0.4% Triton X-100/PBS for 10 min each. The sections were then incubated in protease K (1 mg ml 71 ) in PBS (Sigma) for 30 min at 378C. The activity of protease K was stopped by ®xation in 4% paraformaldehyde for 5 min, followed by 263 min wash in PBS to remove the ®xative from the sections. The sections were incubated in 0.25% acetic anhydride with 0.1 M triethanolamine (pH 8.0) for 10 min at room temperature, followed by washing in 260.6 M sodium chloride, 0.06 M sodium citrate (SSC) for 10 min. Digoxigenin-labelled cRNA (0.1 ± 0.5 mg ml 71 ) of either antisense or sense probes were added to hybridization buer containing 50% formamide, 10% dextran sulphate, 0.3 M NaCl, 16Denhardt's solution, 0.05 M Tris-HCl (pH 8.0), 1 mM EDTA and 250 mg ml 71 E. Coli tRNA (RNasefree) (Sigma). Hybridization was carried out for 16 h at 638C in a hybridization oven. The sections were washed in 46SSC for 20 min at 378C, followed by incubation in 26SSC containing 20 mg ml 71 RNase A (Sigma) for 30 min at 378C to digest the RNA probes that did not hybridize with the targeted RNA. The sections were further washed in 16SSC and 0.26SSC at 378C for 20 min, respectively. A method modi®ed from Kiyama & Emson (1990) was used to detect the hybridization signals. Brie¯y, the sections were ®rst incubated in the blocking buer containing 5% bovine serum albumin and 0.4% Triton X-100 in PBS at room temperature for 30 min, and then with anti-digoxigenin antibody conjugated to alkaline phosphatase (Boehringer Mannheim) diluted 1 : 1000 in the blocking buer for 4 h at room temperature. The sections were washed with PBS for 465 min, followed by washing in 0.1 M Tris-HCl buer, pH 8.0, containing 0.1 M NaCl and 0.01 M MgCl 2 , then equilibrated for 10 min in 0.1 M Tris-HCl buer, pH 9.5, with 0.1 M NaCl and 0.05 M MgCl 2 . The colour development was performed with 400 mg ml 71 nitro blue tetrazolium, 200 mg ml 71 5-bromo-4-chloro-3-indolyl phosphate and 100 mg ml 71 levamisole in 0.1 M TrisHCl buer, pH 9.5, containing 0.1 M NaCl and 0.05 M MgCl 2 , in the dark at room temperature overnight. The sections were rinsed in 10 mM Tris-HCl, 1 mM EDTA, pH 8.0, for 10 min to stop the colour development, then mounted with 50% glycerol in the Tris-HCl/EDTA buer and stored at 48C in the dark.
Immunohistochemistry Sequence analysis has revealed that the C-terminal region is one of the least conserved amongst members of the P2X receptor family. Peptide sequence in this region has been used to generate subtype-selective antibodies (Roche Bioscience). A synthetic peptide corresponding to the C-terminal 15 amino acid residues (458 ± 472) of the rat P2X 2 receptor (QQDSTSTDPKGLAQL; Genbank U14414) was covalently linked to Keyhole Limpet Haemocyanin, and rabbits were immunized with the conjugated peptide in multiple monthly injection (performed by Research Genetics, Inc., Huntsville, AL, U.S.A.). The speci®city of the antisera was veri®ed by immunoblotting with the membrane preparation from CHO-K1 cells expressing the cloned P2X 2 receptor. IgG fractions were isolated from the pre-immune and immune sera following the method of Harboe & Ingild (1973) . The protein concentration was determined at 280 nm using an extinction factor of 1.43 for 1 mg ml 71 . Sections which had been treated as described above were incubated in 0.5% H 2 O 2 and 50% methanol for 10 min to block the endogenous peroxidase. The sections were then preincubated in 10% normal horse serum (Life Technologies) in PBS containing 0.05% methiolate for 20 min, followed by incubation with the primary antibodies diluted to 2.5 mg ml 71 (determined as optimal by previous titrations) in 10% normal horse serum in PBS containing 0.05% methiolate overnight. Subsequently the sections were incubated with biotinylated donkey anti-rabbit IgG (Jackson ImmunoResearch, West Grove, PA, U.S.A.) diluted 1 : 500 in 1% normal horse serum in PBS containing 0.05% methiolate for 1 h, and then with ExtrAvidin-horseradish peroxidase (Sigma) diluted 1 : 1500 in PBS containing 0.05% methiolate for 1 h. All incubations were held at room temperature and separated by 365-min washes in PBS. Finally, freshly prepared colour reaction mixture containing 0.5% 3,3'-diaminobenzidine, 0.1 M sodium phosphate, 0.004% NH 4 Cl, 0.2% glucose, 0.04% nickel ammonium sulphate and 0.1% glucose oxidase were applied to the sections for 5 ± 10 min or until colour product appeared (LlewellynSmith et al., 1993) . The sections were then washed, dehydrated and cleared in xylene, and embedded.
Drugs and materials
ATP, related nucleotides and other chemicals were obtained from Sigma Chemical Co. (Poole, U.K.), except for 2-methylthio-ATP (2MeSATP), which was from RBI-SEMAT, (U.K.). Suramin was a gift from Bayer plc (U.K.), and pyridoxalphosphate -6 -azophenyl -2',4' -disulphonic acid (PPADS) was from Tocris Cookson, U.K. Stock solutions (10 mM, 100 mM) of ATP and other drugs were prepared using deionized water and stored frozen. All drugs were then diluted in extracellular bathing solution. The P2X 2 polyclonal antisera was kindly supplied by Roche Bioscience, Palo Alto, U.S.A. We would like to thank Dr G. Buell of Glaxo-Wellcome Institute of Molecular Biology in Geneva, Switzerland, for providing the rat P2X 1 , P2X 5 and P2X 6 cDNA; Dr T. Blake of University of California, U.S.A., for providing rat P2X 2 cDNA and Dr J. Wood of University College London, U.K., for providing rat P2X 3 cDNA.
Results
Responses to ATP
Rapid application of ATP (100 mM) on to isolated rat MPG neurons voltage clamped at 770 mV induced an inward current in 268/277 cells. However, the peak amplitudes of these responses varied greatly ( Figure 1a ). Only a small response (50.33 nA) was seen in 57.8% cells (160/277) while the remaining 39.0% cells (108/277) gave moderate-to-large inward currents (0.33 ± 5.3 nA), including 11 cells which gave very large responses (42 nA). This was not due simply to the dierence in cell size, since a similar large degree of variation was still observed after normalizing the responses with respect to membrane capacitance (data not shown). A similar variation in the amplitude of inward currents evoked by ATP has been reported previously in dorsal root ganglion neurons (Robertson et al., 1996) , and presumably re¯ects variability in the number of receptors expressed in dierent cells. Despite the large variability in response, the amplitude distribution revealed a single, though highly skewed, population.
The response to ATP occurred very rapidly, with a large increase in membrane conductance (Figure 1b) , consistent with the activation of P2X receptors. The responses to ATP desensitized slowly, with the current produced by 100 mM declining to 43.8+1.7% of control at the end of a 30 s application (n=4). The decay of the current ®tted well to a single exponential curve with a time constant of 24.0+3.4 s, n=5.
Concentration-eect relationships of the agonists
The concentration-eect relationship of ATP is shown in Figure 2 . Fitting the Hill equation to the data gave an EC 50 of 58.9 mM (log EC 50 =74.23+0.06, n=6), and a Hill coecient of 1.24, assuming the same relative E max of 1.55 (see Methods section and Figure 7b ). 2-Methylthio-ATP (2MeSATP), adenosine 5'-O-(3-thiotriphosphate) (ATPgS) and 2',3'-O-(4-benzoylbenzoyl)-ATP (BzATP) were also eective, with 2MeSATP and ATPgS being slightly less potent than ATP (EC 50 s of 85.7 mM and 84.2 mM, respectively, assuming the same maximum response). BzATP was considerably less potent, and although a maximum response was not obtained, the shape of the concentration-eect relationship of BzATP suggests that it may be a partial agonist at this receptor.
a,b-Methylene ATP (a,b-MeATP), b,g-methylene ATP (b,gMeATP), uridine 5'-triphosphate (UTP) and adenosine 5'-diphosphate (ADP) were all inactive at concentations up to 100 mM.
Eects of antagonists
Suramin The P2 receptor antagonist suramin, (Dunn & Blakeley, 1988) , reversibly reduced responses to ATP. With a 3 min pre-incubation, 100 mM suramin reduced responses to ATP (100 mM) to 2.7+1.7% of control (n=4). The responses recovered rapidly and were 69.8+7.2% (n=4) of control 3 min after washing out suramin. This antagonism produced by suramin appeared to be competitive, since the concentration-eect relationship for ATP was shifted to the right in an approximately parallel manner by 10 mM suramin (Figure 3a) . Low concentrations of suramin (1 or 3 mM) have been found to produce approximately parallel, rightward shifts in the ATP concentration-response curves on heterologously expressed P2X 1 and P2X 2 receptors (Evans et al., 1995) , but the shifts in the presence of higher concentrations were no longer parallel. Thus, the eect of suramin on P2X receptors may involve more than a competitive antagonism. Nevertheless, the antagonism by suramin (even at the higher concentration of 100 mM) was readily reversed within a few minutes of washout (e.g. Evans et al., 1995; this study) . In the presence of suramin (10 mM) the concentration-eect relationship of ATP yielded an EC 50 of 221 mM (log EC 50 =73.65+0.02, n=4, signi®cantly dierent from control, P50.0001, Student's t-test), and a Hill-slope of 1.88. Using a 2+2 type protocol, shifts in the concentrationresponse curves for ATP were determined for three concentrations of suramin. From these data, a Schild plot was constructed, which yielded a pA 2 of 5.5 with a slope of 0.63+0.10 (n=4) (Figure 3b ).
Reactive blue-2 Another P2 receptor antagonist, reactive blue-2 (Cibacron Blue 3GA, 65% pure) (Manzini et al., 1986) , was more eective than suramin in inhibiting responses to ATP. At 100 mM, reactive blue-2 was toxic to the MPG neurons (data not shown). Therefore, in this series of experiments, ATP was applied every 2 min. With a 2-min preincubation, 10 mM of reactive blue-2 was able to reduce responses to ATP (100 mM) to 2.5+1.4% of control (n=4), from which there was moderately rapid recovery of responses to 61.8+3.4% of control after a 2-min wash-out. However, the eect of reactive blue-2 did not appear to be competitive, since in the presence of 1 mM reactive blue-2, the E max of the concentration-eect relationship of ATP was reduced (relative E max =0.55+0.06, n=4, signi®cantly dierent from control, P50.001, Student's t-test, Figure 4a) . Inhibition of the response to ATP (100 mM) by reactive blue-2 was concentration dependent (Figure 4b ). Fitting the Hill equation to these data gave an IC 50 of 0.7 mM (log IC 50 =76.15+0.10, n=6).
PPADS PPADS, another P2 receptor selective antagonist (Lambrecht et al., 1992) , was also able to inhibit responses to ATP on MPG neurons. PPADS has two types of action on dierent recombinant P2X receptors. On P2X 1 and P2X 2 , it shows slow onset of inhibition and slow recovery (up to 30 min) after washout, while on P2X 3 , the onset of inhibition and recovery from PPADS is rapid (for review, see Buell et al., 1996a) . On MPG neurons, its kinetics were considerably slower than those of suramin and reactive blue-2. After a 4 min pre-incubation, 10 mM PPADS reduced responses to ATP (100 mM) to 4.7+1.8% of control (n=4) (Figure 5a ). The recovery from the inhibition of PPADS was also slow, with responses to ATP (100 mM) being only 20.5+1.7% of control (n=4) 4 min after washing out the antagonist. The time required for PPADS to inhibit responses of ATP was concentration-dependent. The time pro®le of the inhibition by PPADS of responses to ATP is shown in Figure 5b . These data were well ®tted by the single exponential decay, yielding time constants of 20.1 min, 7.6 min and 0.48 min for 0.3, 1 and 3 mM PPADS respectively (Figure 5b ).
Modulation by pH
Application of external bath solution with pH from 6.8 to 8.0 in the absence of ATP did not activate detectable currents in these neurons (data not shown). However, altering pH produced dramatic changes in the responses to ATP. As shown in Figure 6a , the amplitude of the inward current induced by ATP (30 mM) was increased greatly when pH was reduced from 7.4 to 6.8, and was markedly attenuated when pH was elevated from 7.4 to 8.0. Proton potentiation of currents activated by ATP was rapid and reversible. On average, the current activated by ATP (30 mM) was enhanced at pH 6.8 to 339.2+28.4% (n=4) of that at pH 7.4 (control), while alkalinization to pH 8.0 suppressed the response to 20.2+3.0% of control (n=4) (Figure 6b ).
The concentration-eect relationship for ATP-activated currents at pH 8.0, 7.4 and 6.8 showed that changing pH did not alter the slope of the concentration-eect relationship for ATP, but rather changed the EC 50 s (Figure 6c) , from 58.9 mM at pH 7.4 to 28.8 mM (log EC 50 =74.54+0.04, n=5) and 264 mM (log EC 50 =73.58+0.03, n=5) at pH 6.8 and 8.0 respectively (EC 50 s at pH 6.8 and 8.0 were signi®cantly dierent from that at pH 7.4, P50.01, P50.0001, Student's t-test, respectively).
Modulation by Zn
2+
Application of Zn 2+ in the absence of ATP did not activate detectable currents in these neurons (data not shown). Coapplication of ATP and Zn 2+ (1 ± 100 mM) produced a concentration dependent potentiation of responses to ATP. Fitting the Hill equation to the enhancement by Zn 2+ of responses to ATP (30 mM) yielded an EC 50 for Zn 2+ of 9.55 mM (log EC 50 =75.02+0.14, n=6710) and an E max of 4.49+0.48, with a Hill coecient of 1.24 (Figure 7a ). The concentration-eect relationships for ATP in the absence and presence of Zn 2+ (30 mM) showed a parallel shift, with the EC 50 of ATP decreasing to 4.57 mM (log EC 50 =75.34+0.14, n=5, signi®cantly dierent from control, P50.0001, Student's t-test) in the presence of Zn 2+ (30 mM), while the Hill coecient (1.19) and the E max were not signi®cantly altered (Figure 7b ).
In situ hybridization
In situ hybridization using oligonucleotide probes speci®c for P2X 1 ± 6 receptor mRNAs revealed marked dierence in the levels of these transcripts in rat MPG neurons (Figure 8 ). P2X 2 receptor probe showed strong labelling in many neurons of MPG. However, there was considerable cell to cell variation in the intensity. P2X 4 receptor probe showed much less intense labelling. In contrast, the mRNA levels of P2X 1 and P2X 3 were hardly detectable. The mRNA levels of P2X 5 and P2X 6 receptors were also very low, similar to those of P2X 1 and P2X 3 (not shown). After determination of the control responses to ATP (100 mM), various concentrations of PPADS were applied to the cells, and ATP (100 mM) was reapplied every 2 min. Each concentration of PPADS was tested on a dierent sample of cells. Responses were normalized with respect to that obtained with ATP in the absence of PPADS on the same neuron. Data were ®tted to the single exponential decay, yielding time constants of 20.1 min, 7.6 min and 0.48 min for 0.3, 1 and 3 mM PPADS, respectively, n=4. In the presence of 0.3 mM PPADS, curve ®tting started from 2 min. 
Immunohistochemistry
Since the in situ hybridization revealed a high level of P2X 2 receptor mRNA in many neurons of MPG, we examined this further by using immunohistochemical staining with the polyclonal antibody speci®c for P2X 2 receptor. The immunohistochemical staining revealed weaker staining on MPG compared with the nodose ganglia (Xiang, Z., Bo, X & Burnstock, G., personal communication) . However, a small number of neurons showed speci®c and strong P2X 2 immunoreactivity (Figure 9 ).
Discussion
Our results clearly demonstrated for the ®rst time, the presence of P2X receptors on rat MPG neurons (Figures 1, 8 and 9 ). However, there appears to be great variation in receptor density. Although many neurons contain a high level of P2X 2 receptor transcript, not all neurons show distinct P2X 2 labelling, with only a small percentage of neurons showing strong P2X 2 immunoreactivity. This is in agreement with our electrophysiological data, where out of 277 cells, only 11 cells give very large responses (42 nA) to 100 mM ATP, while 57.8% cells produce only small responses (50.33 nA). Thus, the large variation in the amplitude of inward currents evoked by ATP may re¯ect variability in the number of receptors expressed in dierent cells.
Pharmacological properties of these P2X receptors
Agonists On MPG neurons, ATP, 2MeSATP and ATPgS are full agonists (Figure 2) , while a,b-MeATP and b,g-MeATP are inactive. The lack of response to a,b-MeATP and b,g-MeATP suggest that these purinoceptors are unlikely to be P2X 1 or P2X 3 subtypes (Valera et al., 1994; Chen et al., 1995) . The EC 50 value for ATP on MPG neurons is 58.9 mM, very similar to the value of 59.9 mM reported for P2X 2 subtype (Brake et al., 1994) . Moreover, the responses to ATP desensitize slowly, with a t=24 s (Figure 1a ), which would also be consistent with the characteristic of the P2X 2 subtype. The time constant for the decay of ATP responses on these neurons is longer than that determined for PC12 cells (t=5.6 s) (Nakazawa et al., 1990) , but shorter than that for heterologously expressed P2X 2 (t=57 s) (BraÈ ndle et al., 1997) .
Recently, a splice variant of the P2X 2 receptor has been identi®ed. This P2X 2(b) receptor desensitized four times more rapidly than the original P2X 2 (Simon et al., 1997; BraÈ ndle et al., 1997) . However, the large dierence in desensitization rate observed between these two studies makes comparison with our data inconclusive.
BzATP is ten times more potent than ATP as an agonist at the P2X 7 receptor , but acts as a weak partial agonist on MPG neurons. Although BzATP is also a partial agonist on heterologously expressed P2X 1 and P2X 2 receptors (Evans et al., 1995; King et al., 1996 King et al., , 1997 , it is 40 times more potent on the former (EC 50 =0.6 mM, compared with 23 mM), and even more potent than on MPG neurons (EC 50 estimated to be around 100 mM). The low potency of this agonist on MPG neurons would argue against the involvement of P2X 7 or P2X 1 receptors, but would again be consistent with the presence of P2X 2 receptors.
Antagonists
ATP responses on MPG neurons are antagonized by all three antagonists tested, suramin, reactive blue-2 and PPADS ( Figures 3, 4 and 5) . Reactive blue-2 and PPADS are more potent than suramin. The concentrations needed to achieve 495% inhibition of the response to ATP (100 mM) are 10 mM for reactive blue-2 and PPADS, and 100 mM for suramin. Suramin and reactive blue-2 have moderately fast onset and recovery, while it takes PPADS (53 mM) 10 min or even longer to reach its maximal eect, and the recovery is also slow.
Currently available P2 receptor antagonists exhibit a limited ability to discriminate between subtypes. Since some P2X 4 receptors are insensitive to suramin, reactive blue-2 and PPADS, the sensitivity of the P2X receptors present on MPG neurons to antagonists would indicate that they are not the P2X 4 subtypes. However, it is dicult to rule out P2X 4 simply based on the sensitivity/insensitivity to antagonists. To date, several dierent P2X 4 subtypes have been cloned. While some are almost completely insensitive to suramin, PPADS and reactive blue-2 (Bo et al., 1995; Buell et al., 1996b) , others demonstrate small Soto et al., 1996) to moderate sensitivity to these antagonists (SeÂ gueÂ la et al., 1996) . Furthermore, the human P2X 4 receptors display a notably higher sensitivity to these antagonists than the rat homologue (Garcia-Guzman et al., 1997) .
PPADS produces a slowly reversible antagonism at recombinant P2X 1 , P2X 2 and P2X 5 receptors which has been attributed to the formation of a Schi base with a speci®c lysine residue (Buell et al., 1996a) . At other P2X receptors lacking this lysine, PPADS is a weak but rapidly reversible antagonist. Therefore, the slow kinetics for the action of PPADS on the P2X receptors present on MPG neurons would be consistent with the involvement of either P2X 1 , P2X 2 and P2X 5 receptors.
Modulation by pH
Extracellular pH has very dierent eects on heterologously expressed P2X 1 , P2X 2 , P2X 3 and P2X 4 receptors (Stoop et al., 1997) . The potency of ATP is decreased by acidi®cation in cells expressing P2X 1 , P2X 3 or P2X 4 receptors. However, at the P2X 2 receptor, acidi®cation increases the potency of ATP. The recombinant P2X 2 receptor is so sensitive to the change in extracellular pH, that small acidic and alkaline shifts, as little as 0.03 pH-units, enhance or diminish the responses to ATP, respectively (King et al., 1996; Wildman et al., 1997) . On MPG neurons, lowering the pH from 7.4 to 6.8 produces marked potentiation of the responses to ATP (30 mM), while raising the pH to 8.0 attenuates the responses (Figure 6 ). The anity for ATP of these receptors is enhanced by acidi®cation and decreased in an alkaline solution, which is consistent with the characteristic of the recombinant P2X 2 receptor.
Although the pH modulation observed is consistent with the presence of P2X 2 receptors, the heteromeric P2X 2/3 receptors also have a similar sensitivity to pH as homomeric P2X 2 receptors (Stoop et al., 1997) . Presumably, the pH sensitivity on these heteromultimers is determined by the P2X 2 component. However, our in situ hybridization results would argue against involvement of the P2X 2/3 heteromer. Alternatively, as the P2X 5 receptor exhibits a remarkable similarity to the P2X 2 channel on its agonist pro®le and antagonist sensitivity , it is possible that the a b c d Figure 8 Detection of P2X 1 ± 4 receptor mRNAs in the rat major pelvic ganglia using in situ hybridization with (a) P2X 1 , (b) P2X 2 , (c) P2X 3 and (d) P2X 4 oligonucleotide probes. Bar = 100 mm (a ± d). Distinct labelling was observed with the P2X 2 probe, although there was great variation in the intensity from cell to cell. A much lower but still detectable level of staining was also seen with the P2X 4 probe. Figure 9 Immunohistochemical staining in the rat major pelvic ganglia using a polyclonal antibody speci®c for P2X 2 receptors. While the majority of neurons showed weak staining, a small percentage of neurons showed strong P2X 2 -labelling. Bar=200 mm.
change in extracellular pH might also have similar eects on P2X 5 and P2X 2 receptors. Therefore, although the pH sensitivity of ATP currents on MPG neurons is identical to that of the recombinant P2X 2 phenotype, the involvement of P2X 5 receptor can not be excluded.
Modulation by Zn
2+
Among the P2X receptor family, only P2X 2 and P2X 4 subtypes have been reported to be aected by Zn
. Simultaneous application of Zn 2+ potentiates ATP-activated currents at the recombinant P2X 2 receptor (Brake et al., 1994; Wildman et al., 1998) , as well as the P2X 4 receptor (SeÂ gueÂ la et al., 1996; Garcia-Guzman et al., 1997) . ATP-activated currents are also potentiated by Zn 2+ in rat sensory (nodose) (Li et al., 1993 (Li et al., , 1996 and sympathetic (superior cervical ganglia) neurons (Cloues et al., 1993) , by increasing the open frequency and burst duration of ATP-gated channels (Cloues, 1995; Wright & Li, 1995) . The P2X receptors of rat sensory neurons are thought to be heteromultimeric assemblies of P2X 2 and P2X 3 subunits , while rat sympathetic (superior cervical ganglia) neurons are known to contain P2X 2 transcripts (Collo et al., 1996) . Thus, it seems likely that the presence of P2X 2 subunit confers the sensitivity of these native P2X receptors to Zn 2+ . On MPG neurons, ATP responses are strongly potentiated by Zn 2+ (Figure 7 ). In this eect, Zn 2+ has an EC 50 of 9.6 mM, which is very close to that reported on recombinant P2X 2 receptor (Wildman et al., 1998) . Thus, this feature of the P2X receptors on MPG neurons also shows the characteristics of P2X 2 subtype.
In situ hybridization and immunohistochemical evidence
While the pharmacological characteristics of these receptors are most consistent with them being the P2X 2 type, there is at present insucient information on the P2X 5 receptor to rule it out pharmacologically. Using P2X 1 ± 6 probes to hybridize with the MPG ganglion sections, only P2X 2 probe shows strong labelling, while P2X 4 probe gives some weak labelling and the mRNA levels for P2X 1 , P2X 3 , P2X 5 and P2X 6 are hard to detect. Since there appears to be a high level of P2X 2 receptor transcript in many neurons, we examined the level of P2X 2 receptor protein using an antisera speci®c for the P2X 2 receptor. While not all neurons show distinct P2X 2 labelling, there is a small percentage of neurons which show strong P2X 2 labelling. This great variability in receptor density strongly supports our electrophysiological data, which shows large variation in the peak amplitude of inward currents evoked by ATP. Furthermore, they also support the pharmacological data that P2X 2 is the major subtype of P2X receptors on these neurons.
In the central nervous system, P2X 2 mRNA has been localized in various brain regions using in situ hybridization (Kidd et al., 1995) , while the P2X 2 receptor immunoreactivity has been reported in Purkinje cells, neurons in the granular and molecular layers and deep cerebellar nuclei in cerebellum (Kanjhan et al., 1996) and in several discrete populations of neurons, including those in the olfactory bulb, substantia nigra, ventral tegmental area and the locus coeruleus (Vulchanova et al., 1996) . In the peripheral nervous system, P2X 2 RNA expression is detectable in nodose, superior cervical, coeliac and trigeminal ganglia (for review, see Buell et al., 1996a) . In contrast to P2X 2 , the expression pattern for P2X 5 is very restricted, and has only been detected in the trigeminal and dorsal root ganglia and the mesencephalic nucleus of the trigeminal nerve (Collo et al., 1996) . Furthermore, cDNAs encoding three splice variants of the P2X 2 receptor, P2X 2(b) , P2X 2(c) and P2X 2(d) , were isolated from rat cerebellum (Simon et al., 1997) . Transcripts for P2X 2(b) and P2X 2(c) were present in many structures in the neonatal rat brain and in nodose, dorsal root and superior cervical ganglia. It remains to be seen whether any of these variants are also present on MPG.
Coexpression of more than one receptor subunit?
The coexpression of P2X 2 and P2X 3 receptor subunits are required to produce ATP-gated currents with the properties seen in some sensory neurons . The P2X receptors present on guinea-pig myenteric neurons share some properties with the P2X 4 and P2X 6 receptors. The unusual pharmacological properties might result from the formation of heteromeric receptors from subunits with dierent functional properties (Barajas-LoÂ pez et al., 1996) . In another study, Zhou & Galligan (1996) demonstrated that there are more than one type of P2X receptors on myenteric neurons, one having the properties similar to cloned P2X 1 receptors, and another more like cloned P2X 2 or P2X 5 receptors. The P2X receptors in superior cervical ganglion neurons may represent P2X 2 or P2X 5 subtypes, dierent from those present in nodose and coeliac neurons (Khakh et al., 1995) . In parasympathetic cardiac ganglion neurons, the characteristics of those purinoceptors suggest that they are also heteromultimeric (Fieber & Adams, 1991) .
Our study demonstrates that on pelvic ganglia, unique within the autonomic nervous system because they contain both sympathetic and parasympathetic neurons, there exist P2X receptors similar to those on superior cervical ganglia, and apparently of the P2X 2 subtype. However, in light of the evidence obtained from our in situ hybridization study, where although neurons of the MPG show high levels of P2X 2 receptor transcript they also possess a much lower but clearly detectable level of P2X 4 mRNA, it is possible that the P2X receptors on MPG are heteromultimers, with P2X 2 being the dominant component. Alternative splicing of pre-mRNA is a common phenomenon for other transmitter-gated channels. The recently identi®ed splice variants of P2X 2 receptor (Simon et al., 1997) may increase the number of subunit sequences available for heteromultimeric channel assembly.
Which neurons in MPG express P2X receptors?
As mentioned previously, pelvic ganglia contain a mixture of sympathetic and parasympathetic neurons which are innervated by preganglionic axons from either hypogastric nerve (sympathetic) or pelvic nerve (parasympathetic), respectively. These two types of neurons are present in approximately equal proportions (Keast, 1995) . Of those neurons receiving sympathetic preganglionic innervation, the majority (*75%) of them are noradrenergic (i.e. immunoreactive for tyrosine hydroxylase (TH)), and are also immunoreactive for neuropeptide Y (NPY); the remainder contain vasoactive intestinal peptide (VIP)-immunoreactivity (IR) but not TH-IR and maybe cholinergic. Those neurons receiving parasympathetic preganglionic innervation are virtually all non-noradrenergic (no TH-IR) and are also of two histochemical types, with some neurons containing NPY-IR and others containing VIP-IR (Keast, 1995) . Furthermore, by using the retrograde-tracing technique, the peptide contents of MPG neurons that project to dierent urogenital organs and digestive tracts have been identi®ed (Keast & de Groat, 1989; Luckensmeyer & Keast, 1995) . The results from our study indicated that the density of P2X receptors on the ganglia and the responses to ATP vary widely from cell to cell (Figures 1, 8 and 9 ), and the amplitude distribution indicates a single but highly skewed population (Figure 1) . It remains to be seen whether there is a correlation between the neuron type, their peptide contents and/or their projection to various pelvic organs with the level of P2X receptor expression.
To conclude, we have demonstrated the presence of P2X receptors on rat major pelvic ganglia neurons. The pharmacological characteristics of these receptors, the in situ hybridization and immunohistochemical evidence are all consistent with them being of the P2X 2 subtype, or heteromultimers with P2X 2 being the dominant component.
